Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Recent Advances in the Development of Small-molecule CCR5 Inhibitors for HIV

Author(s): Tao Liu, Zhiyong Weng, Xiaowu Dong and Yongzhou Hu

Volume 10, Issue 13, 2010

Page: [1277 - 1292] Pages: 16

DOI: 10.2174/13895575110091277

Price: $65

Abstract

CCR5 (C-C chemokine receptor type 5) is a chemokine receptor that has been identified as a major HIV coreceptor in viral entry and therefore is a highly validated target for the development of new anti-HIV drugs. Here, we discuss the insights gained so far relevant to the development of small-molecule CCR5 inhibitors for the treatment of HIV, and highlight small-molecule CCR5 inhibitors that are currently under preclinical and clinical trials.

Keywords: HIV, Entry, Co-receptor, CCR5, Small-molecule inhibitor, Maraviroc

« Previous

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy